Back

Rationale for the use of the polypill in cardiovascular disease.

7 April 2017 (16:30 - 16:52)
Organised by:
Congress Presentation Part of: The cardiovascular polypill: practical implementation Miscellaneous Open Access EuroPrevent 2017

About the speaker

Photo
Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Is the polypill effective in primary prevention? The evidence.
Doctor M. Lafeber (Utrecht, NL)
Slides Video
Presentation thumbnail
Is the polypill effective in secondary prevention? The evidence.
Professor V. Barrios (Madrid, ES)
Slides Video
Presentation thumbnail
Practical implementation of the polypill, current status and future challenges.
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Slides Video

Access the full session

Session thumbnail
The cardiovascular polypill: practical implementation

The Event

Event poster

EuroPrevent 2017

7 April 2017 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Polypill to improve adherence in cardiovascular secondary prevention: a real challenge in real practice
3 September 2019
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Session
Essential contribution of nurses and allied professionals in improving global cardiovascular health
23 June 2023
thumbnail
Congress Presentation
Introduction
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources